Retained Earnings (Accumulated Deficit) of CLOVER HEALTH INVESTMENTS, CORP. /DE from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE Retained Earnings (Accumulated Deficit) for the quarter ending 31 Dec 2025 was $2,288,352,000, a 3.9% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,288,352,000 -$85,549,000 -3.9% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $2,239,032,000 -$58,321,000 -2.7% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $2,214,655,000 -$43,099,000 -2% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $2,204,077,000 -$25,113,000 -1.2% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $2,202,803,000 -$43,009,000 -2% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $2,180,711,000 -$91,389,000 -4.4% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $2,171,556,000 -$123,703,000 -6% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $2,178,964,000 -$159,925,000 -7.9% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $2,159,794,000 -$213,361,000 -11% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $2,089,322,000 -$217,786,000 -12% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $2,047,853,000 -$251,625,000 -14% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $2,019,039,000 -$326,992,000 -19% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $1,946,433,000 -$330,418,000 -20% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $1,871,536,000 -$441,999,000 -31% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $1,796,228,000 -$401,218,000 -29% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $1,692,047,000 -$614,648,000 -57% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $1,616,015,000 -$587,033,000 -57% 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $1,429,537,000 -$1,427,169,800 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $1,395,010,000 -$1,394,935,804 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $1,077,399,000 -$1,077,381,369 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $1,028,982,000 -$1,028,964,369 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $2,367,200* 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $74,196* 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $17,631* 31 Mar 2020 10-Q 04 Jun 2020 2020 Q1
Q4 2019 $17,631* 31 Dec 2019 10-K 31 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.